TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice—Brief Report
暂无分享,去创建一个
B. Nieswandt | K. Kunzelmann | J. Heemskerk | Elizabeth J Haining | C. Kleinschnitz | D. Stegner | A. Braun | F. Swieringa | Michael K. Schuhmann | Podchanart Wanitchakool | Sarah Beck | A. Baig | E. Geuss | M. Schuhmann | M. K. Schuhmann | David Stegner
[1] P. Williamson,et al. Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. , 2016, Physiological reviews.
[2] J. Heemskerk,et al. Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[3] B. Nieswandt,et al. Survival protein anoctamin‐6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] G. Stoll,et al. The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats , 2016, PloS one.
[5] L. Ivanciu,et al. Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo , 2015, Journal of thrombosis and haemostasis : JTH.
[6] Christopher M. Williams,et al. Coordinated Membrane Ballooning and Procoagulant Spreading in Human Platelets , 2015, Circulation.
[7] S. Nagata,et al. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets , 2015, Proceedings of the National Academy of Sciences.
[8] R. Ravazzolo,et al. Ion channel and lipid scramblase activity associated with expression of TMEM16F/ANO6 isoforms , 2015, The Journal of physiology.
[9] B. Konkle,et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. , 2015, Blood.
[10] R. Camire,et al. New insights into the spatiotemporal localization of prothrombinase in vivo. , 2014, Blood.
[11] B. Nilius,et al. Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? , 2014, Pflügers Archiv - European Journal of Physiology.
[12] P. Nurden,et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. , 2013, The Journal of clinical investigation.
[13] G. Stoll,et al. Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. , 2013, Blood.
[14] K. Mann,et al. The role of the red cell membrane in thrombin generation. , 2013, Thrombosis research.
[15] S. Nagata,et al. Calcium-dependent Phospholipid Scramblase Activity of TMEM16 Protein Family Members* , 2013, The Journal of Biological Chemistry.
[16] A. Chishti,et al. Dual Mechanism of Integrin αIIbβ3 Closure in Procoagulant Platelets* , 2013, The Journal of Biological Chemistry.
[17] C. Saunders,et al. Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. , 2013, Blood.
[18] P. Münzer,et al. Expression and Functional Significance of the Ca2+-Activated Cl- Channel ANO6 in Dendritic Cells , 2012, Cellular Physiology and Biochemistry.
[19] Y. Jan,et al. TMEM16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets during Blood Coagulation , 2012, Cell.
[20] B. Payrastre,et al. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome , 2011, Journal of thrombosis and haemostasis : JTH.
[21] P. Williamson,et al. Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. , 2011, Blood.
[22] S. Nagata,et al. Calcium-dependent phospholipid scrambling by TMEM16F , 2010, Nature.
[23] B. Nieswandt,et al. Roles of Platelet STIM1 and Orai1 in Glycoprotein VI- and Thrombin-dependent Procoagulant Activity and Thrombus Formation* , 2010, The Journal of Biological Chemistry.
[24] G. Stoll,et al. Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding , 2010, Circulation.
[25] G. Reiser,et al. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: Localization, expression and participation in neurodegenerative diseases , 2008, Thrombosis and Haemostasis.
[26] J. Rosing,et al. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma , 2007, Journal of thrombosis and haemostasis : JTH.
[27] T. Renné,et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.
[28] P. Comfurius,et al. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. , 2004, Biochimica et biophysica acta.
[29] R. Keep,et al. Intracerebral Hirudin Injection Attenuates Ischemic Damage and Neurologic Deficits without Altering Local Cerebral Blood Flow , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] B. Nieswandt,et al. Flow cytometric detection of activated mouse integrin αIIbβ3 with a novel monoclonal antibody , 2002 .
[31] B. Nieswandt,et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. , 2000, Blood.
[32] R. Farndale,et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. , 1999, Cardiovascular research.
[33] J. Heemskerk,et al. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. , 1997, Blood.
[34] L. Pitts,et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.
[35] B. Nieswandt,et al. Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha. , 2001, The Journal of biological chemistry.